Singapore’s MiyaHealth obtains ISO certification and CE mark for its chronic disease management platform

MiyaHealth, a Singapore-headquartered global software as a service (SaaS) HealthTech, has announced that it has secured ISO 13845:2016 certification and a CE Mark for GensuApp, its chronic disease management platform created in partnership with Bioton S.A., a Poland-based biotech company.

Singaporean SaaS HealthTech firm MiyaHealth concludes $7.7M Pre-Series A fundraise for global expansion

MiyaHealth, a Singapore-headquartered software as a service (SaaS) HealthTech firm, has closed SGD 2.4 million ($1.78 million) Pre-Series A extension round amidst the funding winter, bringing the total fundraise to SGD 10.4 million ($7.7 million).

Singapore’s MiyaHealth to expand globally starting with Europe & Asia, digitalizing healthcare systems

In an interview, Rajentheran also shared about MiyaHealth’s plans and strategies moving forward. He also shared his views about the healthcare and HealthTech industry.

Singapore’s MiyaHealth raises additional pre-series A funding for global expansion

MiyaHealth, a Singapore-based HealthTech start-up, has raised an undisclosed sum in additional funding from leading healthcare and technology investors including HealthXCapital, Central Capital Ventura, and SEEDS Capital. The fresh funds will be used to accelerate the company’s product development, hiring, and expansion plans.

Singapore HealthTech firm MiyaHealth secures $4.8M in Pre-Series A round led by ST Engineering Ventures and Elev8

MiyaHealth has raised S$6.5 million ($4.83 million) in a Pre-Series A round led by ST Engineering Ventures and Elev8. Several prominent angel investors from the private equity and healthcare industries also participated in the round. The recent fundraise brings the total capital raised to over S$9 million ($6.69 million), and the current round is one of the…